Smith & Nephew (NYSE:SNN) Downgraded to Hold Rating by Deutsche Bank Aktiengesellschaft

Smith & Nephew (NYSE:SNNGet Free Report) was downgraded by stock analysts at Deutsche Bank Aktiengesellschaft from a “buy” rating to a “hold” rating in a research note issued to investors on Friday, MarketBeat.com reports.

Separately, StockNews.com upgraded Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research report on Monday, August 5th. Two equities research analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Smith & Nephew presently has a consensus rating of “Moderate Buy”.

Check Out Our Latest Stock Report on SNN

Smith & Nephew Trading Up 0.6 %

SNN opened at $25.24 on Friday. Smith & Nephew has a 1-year low of $23.24 and a 1-year high of $31.72. The stock’s 50 day simple moving average is $29.98 and its 200 day simple moving average is $27.81. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51.

Institutional Trading of Smith & Nephew

A number of large investors have recently made changes to their positions in the stock. Janney Montgomery Scott LLC lifted its holdings in Smith & Nephew by 13.8% in the 1st quarter. Janney Montgomery Scott LLC now owns 9,611 shares of the medical equipment provider’s stock valued at $244,000 after purchasing an additional 1,165 shares in the last quarter. Inspire Advisors LLC lifted its stake in shares of Smith & Nephew by 4.7% during the first quarter. Inspire Advisors LLC now owns 21,647 shares of the medical equipment provider’s stock valued at $549,000 after buying an additional 970 shares during the period. Headlands Technologies LLC boosted its position in Smith & Nephew by 225.0% during the first quarter. Headlands Technologies LLC now owns 3,851 shares of the medical equipment provider’s stock worth $98,000 after acquiring an additional 2,666 shares during the last quarter. QRG Capital Management Inc. grew its stake in Smith & Nephew by 47.0% in the 1st quarter. QRG Capital Management Inc. now owns 93,034 shares of the medical equipment provider’s stock worth $2,359,000 after acquiring an additional 29,754 shares during the period. Finally, Henry James International Management Inc. raised its holdings in Smith & Nephew by 12.2% in the 1st quarter. Henry James International Management Inc. now owns 205,417 shares of the medical equipment provider’s stock valued at $5,209,000 after acquiring an additional 22,341 shares during the last quarter. Institutional investors and hedge funds own 25.64% of the company’s stock.

About Smith & Nephew

(Get Free Report)

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

See Also

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.